| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 6,554.0 | 6,053.0 |
| Gross profit | 3,837.0 | 3,523.0 |
| Profit before tax | 1,132.0 | 1,076.0 |
| Net income | 1,235.0 | 908.0 |
| EPS (diluted, $ a share) | $1.75 | $1.27 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +36.0% |
|---|---|
| Revenue, year on year | +8.3% |
| Gross margin | 58.5% |
| Operating margin | 19.0% |
10-Q filed with the SEC, NYSE: DHR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Danaher Corp: key numbers
- Share price
- $229.91Close, Nov 16
- Market cap
- $162B
- Shares outstanding
- 703.53MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Industrial Instruments For Measurement, Display, and ControlSIC 3823
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Danaher Corp
All →Danaher EVP Gregory M. Milosevich Sells $484K of Stock
Gregory M. Milosevich, EVP, sold 2,100 shares of Danaher Corp at $230.62 a share, worth $484K in total on Nov 9, 2026. Shares held after the trade: 22,367 (-8.6%).
- Value
- $484K
- Shares
- 2,100
- Price
- $230.62
- Role
- EVP
- Holding change
- -8.6%
- Trade date
- Nov 9, 2026
Danaher EVP Matthew McGrew Sells $4.1M of Stock
Matthew McGrew, EVP, sold 17,385 shares of Danaher Corp at $235.69 a share, worth $4.1M in total on Nov 9, 2026. Shares held after the trade: 12,674 (-57.8%).
- Value
- $4.1M
- Shares
- 17,385
- Price
- $235.69
- Role
- EVP
- Holding change
- -57.8%
- Trade date
- Nov 9, 2026
Danaher VP, CAO Christopher Bouda Sells $1.78M of Stock
Christopher Bouda, VP, CAO, sold 7,598 shares of Danaher Corp at $234.54 to $234.58 a share (average $234.56) in 2 transactions, worth $1.78M in total on Oct 28, 2026. Shares held after the trade: 9,107 (-26.3%).
- Value
- $1.78M
- Shares
- 7,598
- Average price
- $234.56
- Role
- VP, CAO
- Holding change
- -26.3%
- Trade date
- Oct 28, 2026
Danaher EVP Matthew McGrew Sells $7.01M of Stock
Matthew McGrew, EVP, sold 29,754 shares of Danaher Corp at $235.35 to $236.09 a share (average $235.74) in 2 transactions, worth $7.01M in total on Oct 28, 2026. Shares held after the trade: 12,674 (-55.2%).
- Value
- $7.01M
- Shares
- 29,754
- Average price
- $235.74
- Role
- EVP
- Holding change
- -55.2%
- Trade date
- Oct 28, 2026
Danaher Financial Results
Danaher reported third quarter 2026 revenues of $6.6 billion, an 8.5% increase year-over-year, with net earnings rising 34.5% to $1.2 billion. The company raised its full-year 2026 adjusted diluted net earnings per share guidance to a range of $8.57 to $8.62, citing improving trends across end markets.
- Term
- Q3 2026
“We delivered better-than-expected third quarter revenue, earnings and cash flow, and are encouraged by the improving trends we saw across our end markets. The continued acceleration in core revenue growth excluding respiratory revenue, together with DBS-driven execution drove double-digit adjusted EPS growth and underscored our ability to convert improving demand into strong financial performance.”
Julie Sawyer Montgomery, President and Chief Executive Officer
“Looking forward, the opportunity for Danaher is clear: to become the defining leader in Life Sciences and Diagnostics–a company that unambiguously gains share, delivers sustainable profitable growth, and helps our customers improve outcomes for patients around the world.”
Julie Sawyer Montgomery, President and Chief Executive Officer
Danaher Leadership Change
Danaher Corporation increased its Board of Directors to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg as new directors, effective October 9, 2026. Mr. Comas is the company's former CFO, and Dr. Hershberg is the former CEO of HilleVax, Inc. Both will serve until the next annual meeting and participate in the standard non-employee director compensation program.